Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients

Sundelin K., Seal D., Gardner S., Ropo A., Geldsetzer K., Lokkila J., Stenevi U.

2009
Acta Ophthalmologica

View publication

Therapeutic Area

Other
Categories

Clinical development

Affiliations

Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal, SE-431 80 Mölndal, Sweden; Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Sweden; Applied Vision Research Centre, City University, London, United Kingdom; OTM Inc., Atlanta, GA, United States; Santen Oy, Tampere, Finland; Department of Research and Development, Santen GmbH, Germering, Germany; Laboratory Center, Santen Oy, Tampere, Finland

Related Publications

Enhancing Corneal Drug Penetration Using Penetratin for Ophthalmic Suspensions

Morofuji R.; Kudo K.; Honda T.; Kinugasa S.; Matsuo T.; Okabe K.

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Kempen J.H.; Newcomb C.W.; Washington T.L.; Foster C.S.; Sobrin L.; Thorne J.E.; Jabs D.A.; Suhler E.B.; Rosenbaum J.T.; Sen H.N.; Levy-Clarke G.A.; Nussenblatt R.B.; Bhatt N.P.; Lowder C.Y.; Goldstein D.A.; Leiderman Y.I.; Acharya N.R.; Holland G.N.; Read R.W.; Dunn J.P.; Dreger K.A.; Artornsombudh P.; Begum H.A.; Fitzgerald T.D.; Kothari S.; Payal A.R.; Daniel E.; Gangaputra S.S.; Kaçmaz R.O.; Liesegang T.L.; Pujari S.S.; Khachatryan N.; Maghsoudlou A.; Suga H.K.; Pak C.M.; Helzlsouer K.J.; Buchanich J.M.

Exploring Cell-Penetrating Peptides as Penetration Enhancers in Eye Drop Formulations Using a Reconstructed Human Corneal Epithelial Model

Morofuji R.; Enomoto H.; Honda T.; Oyama Y.; Ishida R.; Kudo K.; Okabe K.

View all Other publications